CK Life Sciences Int'l., (Holdings) Inc. 00775.HK 上一季度的收入表现如何?
CK Life Sciences Int'l., (Holdings) Inc. 的收入预期是多少?
CK Life Sciences Int'l., (Holdings) Inc. 的盈利质量评分是多少?
CK Life Sciences Int'l., (Holdings) Inc. 何时发布财报?
CK Life Sciences Int'l., (Holdings) Inc. 的预期收益是多少?
CK Life Sciences Int'l., (Holdings) Inc. 是否超出收益预期?
关键数据
前收盘价
$0.84
开盘价
$0.83
当日区间
$0.83 - $0.84
52周范围
$0.45 - $1.1
交易量
558.0K
平均成交量
5.9M
每股收益(TTM)
-0.03
股息收益率
--
市值
$8.0B
什么是 CKLIFE SCIENCES?
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. The company employs 1,935 full-time employees The company went IPO on 2002-07-16. The firm is mainly engaged in human health businesses such as research and development, production, promotion and sales of health products and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.